Evidence map›Paper›PMID 22377533›Full record

ArticleJournal of lipid research2012

Cholesterol level influences opioid signaling in cell models and analgesia in mice and humans.

Hui Zheng, Haibo Zou, Xiaopeng Liu, Ji Chu, Yali Zhou, Horace H Loh, Ping-Yee Law

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 37 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Lipid rafts as viral entry routes and immune platforms: A double-edged sword in SARS-CoV-2 infection?Biochimica et biophysica acta. Molecular and cell biology of lipids · 2022
    Review
  9. Article
  10. Membrane cholesterol dependence of cannabinoid modulation of glycine receptor.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Hui ZhengKey Laboratory of Regenerative Biology, South China Institute for Stem Cell Biology and Regenerative Medicine, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China. zheng_hui@gibh.ac.cn
Haibo Zou
Xiaopeng Liu
Ji Chu
Yali Zhou
Horace H Loh
Ping-Yee Law
University of Minnesota · USChinese Academy of Sciences · CNGuangzhou Institutes of Biomedicine and Health · CN

Funding

Subcellular Targeting/Packaging of Opioids/ReceptorsP50DA011806 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI WICKMAN, KEVIN D · 1998 to 2012
$14.0M
Engineered Opioid Receptors as Therapeutic Agents for Pain ControlR01DA023905 · NIDA · UNIVERSITY OF MINNESOTA · PI LAW, PING-YEE · 2008 to 2012
$2.1M
Neurochemical Basis of Opiate AddictionR56DA000564 · NIDA · UNIVERSITY OF MINNESOTA · PI LAW, PING-YEE, LOH, HORACE · 2012 to 2013
$329k
NIDA NIH HHS DA-011806NIDA NIH HHS DA-023905NIDA NIH HHS P50 DA011806NIDA NIH HHS R01 DA023905NIDA NIH HHS R56 DA000564
6 · The paper itself

Abstract

Cholesterol regulates the signaling of µ-opioid receptor in cell models, but it has not been demonstrated in mice or humans. Whether cholesterol regulates the signaling by mechanisms other than supporting the entirety of lipid raft microdomains is still unknown. By modulating cholesterol-enriched lipid raft microdomains and/or total cellular cholesterol contents in human embryonic kidney cells stably expressing µ-opioid receptor, we concluded that cholesterol stabilized opioid signaling both by supporting the lipid raft's entirety and by facilitating G protein coupling. Similar phenomena were observed in the primary rat hippocampal neurons. In addition, reducing the brain cholesterol level with simvastatin impaired the analgesic effect of opioids in mice, whereas the opioid analgesic effect was enhanced in mice fed a high-cholesterol diet. Furthermore, when the records of patients were analyzed, an inverse correlation between cholesterol levels and fentanyl doses used for anesthesia was identified, which suggested the mechanisms above could also be applicable to humans. Our results identified the interaction between opioids and cholesterol, which should be considered in clinics as a probable route for drug-drug interaction. Our studies also suggested that a low cholesterol level could lead to clinical issues, such as the observed impairment in opioid functions.

Indexed as

AnalgesiaSignal TransductionAnalgesics, OpioidAnimalsCholesterolCholesterol, DietaryDose-Response Relationship, DrugFemaleFentanylHEK293 CellsHumansMaleMembrane MicrodomainsMiceMorpholinesNeuronsAnalgesics, OpioidCholesterolCholesterol, DietaryFentanylMorpholinesReceptors, Opioid, muRV 538Simvastatin

Identifiers

PMID22377533
PMCPMC3351822
OpenAlexW1981445108

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.